Lingfeng Diao
Zhejiang Chinese Medical University(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Jiangsu Cancer Hospital(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer Mechanisms and Therapy, Inflammatory Myopathies and Dermatomyositis, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis(2018)48 cited
- → Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE(2024)16 cited
- → A Transcriptomic Biomarker for Predicting the Response to TACE Correlates with the Tumor Microenvironment and Radiomics Features in Hepatocellular Carcinoma(2024)4 cited
- → Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study(2024)3 cited
- → Unraveling the mysteries of the gut-kidney axis: the protective role of traditional Chinese medicine in chronic kidney disease(2025)3 cited
- → Lenvatinib plus immunotherapy versus lenvatinib monotherapy in lenvatinib-insensitive patients with unresectable hepatocellular carcinoma: a retrospective study